Verge HealthTech Fund | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

Verge HealthTech Fund is an investment management firm based in Singapore that focuses on venture capital investments in the health...


Verge HealthTech Fund LinkedIn profile Verge HealthTech Fund X profile
Verge HealthTech Fund logo

Verge HealthTech Fund is an investment management firm based in Singapore that focuses on venture capital investments in the health tech sector. The fund seeks to support founders globally who are developing transformative healthcare technologies, investing at the earliest stages, and partnering with them to create innovative solutions that enhance healthcare accessibility.

Website
Headquarters
Singapore, Singapore
Size
1-10 employees
Industry
Investment Management
Specialities
Venture Capital, HealthTech, Global, Impact

πŸ›οΈ Verge HealthTech Fund Product and Pricing News β†’

πŸ‘” Verge HealthTech Fund CEO, Management and Leadership Team β†’

βš”οΈ Verge HealthTech Fund Alternatives and Competitors β†’

πŸ’Ό Verge HealthTech Fund Hiring and Layoffs β†’

πŸ€– Verge HealthTech Fund Developer, Integration and Automation News β†’

πŸ“ˆ Verge HealthTech Fund Financials, Fundraising and Valuation News β†’

Monitor your competitors, key accounts, or your own company with RivalSense AI

πŸ›οΈ Verge HealthTech Fund Product and Pricing News

  • Verge HealthTech Fund's Managing Partner, Joseph Mocanu, will judge the Pitch Contest at Takeoff Tokyo on March 25-26.
  • Verge HealthTech Fund's Managing Partner Joseph Mocanu and reach52's CEO Edward Booty will speak at the AVPN Southeast Asia Summit 2025 in Singapore on February 24-25.
  • Joseph Mocanu from Verge HealthTech Fund will speak at HealthHack 2025 on February 8.
  • Erki MΓΆlder, Managing Partner at Verge HealthTech Fund, attended SuperReturn Saudi Arabia 2025 on January 27-28.
  • Verge HealthTech Fund is showcasing its portfolio companies at the Arab Health Exhibition in the Middle East from January 28-30.

  • Joseph Mocanu, Managing Partner at Verge HealthTech Fund, will be a featured speaker at LSI Asia '25 in Singapore from June 10-13.
  • Verge Health Tech Fund's portfolio company Pathway has reached 1 million users and introduced new features including a reasoning model for medicine, voice responses, and expanded free access.
  • Verge HealthTech Fund is listed among the venture investors participating in SOSV's Women's Health VC-Founder Matchup virtual event from February 3-7.

πŸ‘” Verge HealthTech Fund CEO, Management and Leadership Team


βš”οΈ Verge HealthTech Fund Alternatives and Competitors

  • Evergy Ventures
  • |
  • Creative Thinking Ventures
  • |
  • Bridge Partners
  • |
  • OTB Ventures
  • |
  • Lafayette Square
  • |
  • Crestpoint Capital
  • |
  • Navia Partners
  • |
  • Headway Capital Partners
  • |
  • HX Venture Fund
  • |
  • ShiftKey
  • |
  • HealthVerity
  • |
  • Flywheel
  • |
  • RLDatix
  • |
  • Medallion
  • |
  • Axuall
  • |
  • andros
  • |
  • MEDITECH

Monitor your competitors, key accounts, or your own company with RivalSense AI


πŸ’Ό Verge HealthTech Fund Hiring and Layoffs

  • Verge HealthTech Fund welcomes Aparna Krishnan as their newest Venture Partner to support healthcare innovation in South Asia.
  • Lincoln Heng has joined Verge HealthTech Fund as an Investment Analyst in Hong Kong SAR, previously holding a position as an Investment Analyst.


πŸ€– Verge HealthTech Fund Developer, Integration and Automation News


πŸ“ˆ Verge HealthTech Fund Financials, Fundraising and Valuation News

  • Verge HealthTech Fund announced an investment in Macuject, which uses AI to improve treatment for age-related macular degeneration.
  • Verge HealthTech Fund co-led a Β£1.8m seed round for a University of Manchester health tech spinout focused on severe mental illness.
  • Verge HealthTech Fund co-led a Β£1.8 million seed investment in CareLoop Health, a digital therapeutic platform for severe mental illness, alongside Praetura Ventures.
  • Verge HealthTech Fund led a €4.4 million pre-Series A funding round for Prosoma, focusing on oncology care.
  • Verge HealthTech Fund updated the stage of MX Labs from 'Pre-regulatory' to 'Early Revenue', indicating a shift towards revenue generation.

  • Verge HealthTech Fund's portfolio company Nostra Biome has progressed from the pre-regulatory stage to generating early revenue.

People also viewed